
Biotechnology • Pharmaceuticals • Healthcare Insurance
TriSalus Life Sciences is focused on transforming treatment outcomes for patients with solid tumors, particularly liver and pancreatic tumors. The company is developing innovative delivery technologies to address critical barriers—such as intratumoral pressure and immunosuppression—that limit the efficacy of standard immunotherapies. By integrating these advancements with existing therapies, TriSalus aims to enhance the delivery and effectiveness of treatments for these challenging cancers.
51 - 200 employees
Founded 2009
🧬 Biotechnology
💊 Pharmaceuticals
⚕️ Healthcare Insurance
April 23
Direct strategic marketing initiatives for TriSalus, focusing on KOL management and education.